Mirum Pharmaceuticals Inc

Research Mirum Pharmaceuticals Inc (MIRM) on Bullrun: market cap USD 7.50B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerMIRM
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 7.50B
• Financial periodFY2025
• RevenueUSD 521.31M
• Revenue growth54.7%
• Net income-USD 23.36M
• Free cash flowUSD 54.87M

Valuation Snapshot

latest market cap is USD 7.50B.

About Mirum Pharmaceuticals Inc

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. Its lead product candidate is LIVMARLI (maralixibat), an orally administered and minimally absorbed ileal bile acid transporter (IBAT) inhibitor that is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the United States and internationally.

Frequently asked questions

What is Mirum Pharmaceuticals Inc's market cap?

Mirum Pharmaceuticals Inc's market capitalization is USD 7.50B.

What does Mirum Pharmaceuticals Inc do?

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.